|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Venous and arterial thromboembolism in patients with inflammatory bowel diseases显示文摘The risk of thromboembolism(TE)is increased in patients with inflammatory bowel disease(IBD),mainly due to an increased risk of venous TE(VTE).The risk of arterial TE(ATE)is less pronounced,but an increased risk of cardiovascular diseases needs to be addressed in IBD patients.IBD predisposes to arterial and venous thrombosis through similar prothrombotic mechanisms,including triggering activation of coagulation,in part mediated by impairment of the intestinal barrier and released bacterial components.VTE in IBD has clinical specificities,i.e.,an earlier first episode in life,high rates during both active and remission stages,higher recurrence rates,and poor prognosis.The increased likelihood of VTE in IBD patients may be related to surgery,the use of medications such as corticosteroids or tofacitinib,whereas infliximab is antithrombotic.Long-term complications of VTE can include post-thrombotic syndrome and high recurrence rate during post-hospital discharge.A global clot lysis assay may be useful in identifying patients with IBD who are at risk for TE.Many VTEs occur in IBD outpatients;therefore,outpatient prophylaxis in high-risk patients is recommended.It is crucial to continue focusing on prevention and adequate treatment of VTE in patients with IBD. | Antoni Stadnicki Izabela Stadnicka | 2021 | World Journal of Gastroenterology2021，27，40： | 3 |
| 2 | Ezetimibe-a new approach in hypercholesterolemia management显示文摘 | Suchy D Labuzek K Stadnicki A | 2011 | Pharmacol Rep2011，63，13： | 1 |
| 3 | Ezetimibe-a new approach in hypercholesterolemia management显示文摘 | SUCHY D LABUZEK K STADNICKI A | | 0，，06： | 1 |
| 4 | The effect of medial amygdalotorny and anterior hippocampotomy on behavior and seizures in epileptic patients 显示文摘 | Mepel E Witkiewicz B Stadnicki R | 1980 | Acta Neurochir Suppl (Wien)1980，30，： | 1 |
| 5 | Ezetimibe--a new ap-proach in hypercholesterolemia management显示文摘 | Suchy D Labuzek K Stadnicki A | 2011 | Pharmacol Rep2011，63，6： | 1 |
| 6 | Invariant subspace method for eigenvalue computation显示文摘 | Stadnicki D J Ness J V | 1993 | IEEE Trans on Power Systems1993，8，2： | 1 |
| 7 | Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease显示文摘 | Stadnicki A Mazurek U Plewka D | 2003 | Int Immunopharmacol2003，3，7： | 1 |
| 8 | Coagulation Systems and Neutrophils in the Activation of Plasma Contact and Active Phase of Ulcerative Colitis显示文摘 | Antoni Stadnicki Maciej Gonciarz Tomasz J. Niewiarowski Jacek Hartleb Marek Rudnicki Nancy B. Merrell Raul A. Dela Cadena Robert W. Colman | 1997 | Digestive Diseases and Sciences1997，，11： | 1 |
| 9 | Coagulation Systems and Neutrophils in the Activation of Plasma Contact and Active Phase of Ulcerative Colitis显示文摘 | Antoni Stadnicki Maciej Gonciarz Tomasz J. Niewiarowski Jacek Hartleb Marek Rudnicki Nancy B. Merrell Raul A. Dela Cadena Robert W. Colman | 1997 | Digestive Diseases and Sciences1997，，11： | 1 |
| 10 | Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat显示文摘 | Stadnicki A Uknis AB | 1995 | FASEB J1995，9，： | 1 |
| 11 | Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat显示文摘 | STADNICKI A DELA CADENA RA SARTOR RB | 1996 | Dig Dis Sci1996，41，5： | 1 |
| 12 | Ezetimibe-a new approach in hypercholesterolemia management显示文摘 | Dariusz Suchy Krzysztof Labuzek Antoni Stadnicki | 2011 | Pharmacol Rep2011，63，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员